House Bill
H.R. 1349
Women’s Protection in Telehealth Act
Primary Sponsor

Dan Sachs Goldman
Representative
Cosponsors
7
Quick Stats
Policy Area
Summary
This bill restricts telehealth prescribing of abortion-inducing drugs under Medicare. Only physicians who physically examine the patient, are present when the drug is administered, and schedule an in-person follow-up within 14 days can participate in Medicare for these prescriptions.
Latest Action
Referred to the Committee on Ways and Means, and in addition to the Committee on Energy and Commerce, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.